EFFECTS OF LOW-DOSE CADMIUM ON PROSTATE CELLS
低剂量镉对前列腺细胞的影响
基本信息
- 批准号:6164041
- 负责人:
- 金额:$ 36.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from Applicant's Abstract): Chronic low-level exposure to
environmental toxins, including cadmium, is an enormous and growing problem in
the industrialized world. cadmium is a potent carcinogen in rodents and has
also been linked to human lung and prostate cancer, a malignant disease with an
increasing mortality. In vitro models of experimental cadmium toxicity is
proposed to study the molecular mechanisms of prostate epithelia cell injury
and repair. One promising strategy for protection from toxins is the use of low
doses of chemicals to enhance cell tolerance and recovery, a phenomenon known
as hormesis. This strategy is also the theoretical basis for the observed
effects in homeopathy. The homeopathic literature has for decades reported the
use of cadmium for the treatment of cancer. Low and very-low-dose cadmium doses
induce gene expression of protective proteins (metallothonein (MT) and heat
shock) and reduce mortality to toxic doses both in vitro and in vivo. In
preliminary research it was demonstrated that medium dose cadmium exposure
altered gene expression patterns, enhanced protective protein (MT) levels and
protected against acute cadmium toxicity in human prostate epithelial cells.
The objective of this project is to determine the tissue specific molecular
signatures produced by low dose levels of cadmium and to identify the optimal
doses that protect against toxic injury. When completed we will have developed
a novel and highly sensitive approach for detecting and treating toxic
exposures. We will also have developed, for the first time, a systematic model
for the scientific study of protective hormesis and homeopathy in environmental
toxicology and prostate disease.
描述(改编自申请人摘要):慢性低水平暴露于
环境毒素,包括镉,是一个巨大的和日益严重的问题,
工业化世界。镉是啮齿动物体内的一种强致癌物质,
还与人类肺癌和前列腺癌有关,这是一种恶性疾病,
增加死亡率。实验性镉毒性的体外模型是
研究前列腺上皮细胞损伤的分子机制
和修复。一个有希望的策略,保护免受毒素是使用低
剂量的化学物质,以提高细胞的耐受性和恢复,一种现象,
作为毒物兴奋效应。这一战略也是观察到的理论基础
顺势疗法的效果顺势疗法文献几十年来一直报道,
镉在癌症治疗中的应用。低剂量和极低剂量镉剂量
诱导保护性蛋白(金属硫蛋白(MT)和热)基因表达
休克)和降低体外和体内毒性剂量死亡率。在
初步研究表明,中等剂量镉暴露
改变基因表达模式,增强保护蛋白(MT)水平,
在人前列腺上皮细胞中保护免受急性镉毒性。
本项目的目的是确定组织特异性分子
低剂量镉产生的信号,并确定最佳的
保护免受毒性伤害的剂量。完成后,我们将开发
一种新的高灵敏度的检测和治疗有毒物质的方法,
暴露。我们还将首次开发出一个系统的模型,
环境中保护性兴奋效应和顺势疗法的科学研究
毒理学和前列腺疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAYNE B JONAS其他文献
WAYNE B JONAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAYNE B JONAS', 18)}}的其他基金
Complex Isopathic Drug Development for Neuroprotection
用于神经保护的复杂同向药物开发
- 批准号:
6431273 - 财政年份:2002
- 资助金额:
$ 36.74万 - 项目类别:
Complex Isopathic Drug Development for Neuroprotection
用于神经保护的复杂同向药物开发
- 批准号:
6621275 - 财政年份:2002
- 资助金额:
$ 36.74万 - 项目类别:
NEUROPROTECTION WITH GLUTAMATE AND ARNICA MONTANA
谷氨酸和山金车蒙大拿的神经保护
- 批准号:
6083988 - 财政年份:2000
- 资助金额:
$ 36.74万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 36.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 36.74万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 36.74万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 36.74万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 36.74万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 36.74万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 36.74万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 36.74万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 36.74万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 36.74万 - 项目类别: